3.1.0 bicyclic GlyT1 inhibitors and methods of making and using same

Details for Australian Patent Application No. 2009335120 (hide)

Owner Vanderbilt University

Inventors Lindsley, Craig W.; Conn, P. Jeffrey; Weaver, Charles David; Niswender, Colleen M.; Williams, Richard; Jones, Carrie K.; Sheffler, Douglas J.

Agent Davies Collison Cave

Pub. Number AU-A-2009335120

PCT Pub. Number WO2010/078348

Priority 61/141,030 29.12.08 US

Filing date 29 December 2009

Wipo publication date 8 July 2010

International Classifications

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

Event Publications

7 July 2011 PCT application entered the National Phase

  PCT publication WO2010/078348 Priority application(s): WO2010/078348

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009335121-Tissue roll scaffolds

2009335119-System for providing fluid flow to nerve tissues